SIMCERE PHARMA: (I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND; (IV) PROPOSED AMENDMENTS TO THE 2021 RSU SCHEME AND (V)

香港交易所 · May 24, 2023 16:31

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

先聲藥業：(I) 建議授出發行及購回股份之一般授權；(II) 建議重選退任董事；(III) 建議宣派及派付末期股息；(IV) 建議修訂二零二一年受限制股份單位計劃及(V) 股東週年大會通告

SIMCERE PHARMA: (I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND; (IV) PROPOSED AMENDMENTS TO THE 2021 RSU SCHEME AND (V)

Risk Disclaimer

Statement